Skin cancer

July 2012


Facial rash

A case study

Volume 41, No.7, July 2012 Pages 503-504

Kam Cheong Wong

Case study

A male university student, 24 years of age, presented to his general practitioner because of a facial rash. He had a past history of eczema but no other significant past medical history and no allergies. He was not taking any regular medications.

One week earlier, he had experienced a low grade fever and a sore throat associated with a flare-up of his eczema. At that time, he had seen another GP who prescribed mometasone furoate 0.1% (1 mg/g) ointment, one application daily, and oral cephalexin 500 mg, two tablets twice daily. The patient was compliant with this treatment but now reported that since the initial consultation, the rash had worsened (Figure 1).

Figure 1. Facial rash on patient

Figure 1. Facial rash on patient

Question 1

Describe the rash shown in Figure 1.

Question 2

What physical examination would you perform?

Question 3

What is the differential diagnosis?

Question 4

What investigations would you perform?

Case study continued

The patient was afebrile and normotensive with a regular heart rate of 62 bpm. He had cervical lymphadenopathy, which was more significant in the right anterior triangle of the neck. The rash was confined to his face. Eye examination was unremarkable. A skin swab sent for viral polymerase chain reaction showed herpes simplex virus type 1, and microscopy culture and sensitivity results were unremarkable.

Question 5

What is the diagnosis?

Question 6

What other skin disorders may be associated with this condition?

Question 7

What complications can be associated with this condition?

Question 8

What treatment would you prescribe?

Answer 1

Figure 1 shows an erythematous vesiculo pustular rash with crusting and umbilications covering the patient's forehead, cheeks and peri-orbital areas.

Answer 2

It is important to examine the skin on the patient's face, head and neck as well as the torso and limbs. Vital signs and lymph nodes should be assessed and eye examination performed if there is any suggestion of eye involvement.

Answer 3

The differential diagnosis includes eczema, eczema herpeticum, bacterially infected eczema, impetigo, varicella zoster infection and disseminated (systemic) herpes simplex virus (HSV).1

Answer 4

Skin swabs should be performed for viral polymerase chain reaction (PCR) and microscopy culture and sensitivity. Serology and skin biopsy are of little diagnostic value and are not recommended routinely.2

Answer 5

The diagnosis is eczema herpeticum, also known as Kaposi varicelliform eruption. Eczema herpeticum can occur at any age and is caused by close contact with a person who has active lesions of HSV infection, either clinical or subclinical.3,4 While the vast majority of eczema herpeticum cases are caused by HSV (HSV1 and HSV2), cocksackie virus A16 and vaccinia virus have also been implicated.3

Answer 6

Other skin disorders that may be associated with eczema herpeticum include Darier disease, pemphigus foliaceus, and benign familial pemphigus (Hailey-Hailey disease). Rarer associations include Grover disease, ichthyosis vulgaris, contact dermatitis, psoriasis, Pityriasis rubra pilaris, cutaneous T-cell lymphoma (mycosis fungoides), and Wiscott-Aldrich syndrome.1

Answer 7

A primary episode of eczema herpeticum usually resolves in 2–6 weeks.1 However, early recognition and treatment is important as complications, including herpes keratitis (ocular HSV infection), disseminated infection with visceral involvement, and death, may occur.5,6 The mortality rate ranges from 10–50%,1 with the highest risk in immunocompromised patients. Failure to recognise eczema herpeticum and subsequent treatment for an exacerbation of eczema with high dose corticosteroids can result in significant progression of herpes keratitis.7,8 Delay of initiation of aciclovir has been shown to increase length of stay in hospitalised children with eczema herpeticum.9

Answer 8

Recommended treatment for this patient is oral aciclovir or valaciclovir. Aciclovir is generally considered to be safe in pregnancy (pregnancy category B).10–13

It may be difficult to distinguish between eczema herpeticum and secondary bacterially infected eczema, especially if the rash has a crusty appearance, as seen in this patient. In these cases it is reasonable to prescribe a course of oral antibiotics.14 This was not necessary in this patient as the antibiotic (cephalexin) had not been effective and the skin swab was unremarkable.

Figure 2. The patient after treatment

Figure 2. The patient after treatment

Case study follow up

The patient was treated with a course of valaciclovir 500 mg, two tablets three times daily and the rash resolved in 1 week (Figure 2). The patient continues to regularly use a moisturiser and avoids irritants that exacerbate his eczema.

Conflict of interest: none declared.


I would like to thank the patient for his consent to publish this case report, including his photograph.


  1. Wolff K, Johnson RA. Fitzpatrick's color atlas and synopsis of clinical dermatology. 6th edn. New York: McGraw Hill, 2009.
  2. Bork K, Brauninger W. Increasing incidence of eczema herpeticum: analysis of seventy-five cases. J Am Acad Dermatol 1988;19:1024–9.
  3. Hasegawa K, Obermeyer Z, Milne LW. Eczema herpeticum. J Emerg Med 2011;Aug 16 [Epub ahead of print].
  4. Olson J, Robles DT, Kirby P, Colven R. Kaposi varicelliform eruption (eczema herpeticum). Dermatol Online J 2008;14:18.
  5. Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC. Dermatology. 2nd edn. Berlin: Springer, 2000.
  6. Fitzpatrick JE, Aeling JL. Dermatology Secrets in Color. 2nd edn. Philadelphia: Hanley & Belfus, 2001.
  7. Feye F, Halleux CD, Gillet J, Vanpee D. Exacerbation of atopic dermatitis in the emergency department. Eur J Emerg Med 2004;11:360–2.
  8. Studdiford JS, Valko GP, Belin LJ, Stonehouse AR. Eczema herpeticum: making the diagnosis in the emergency department. J Emerg Med 2011;40:167–9.
  9. Aronson PL, Yan AC, Mittal MK, Mohamad Z, Shah SS. Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum. Pediatrics 2011;128:1161–7.
  10. DiCarlo A, Amon E, Gardner M, Barr S, Ott K. Eczema herpeticum in pregnancy and neonatal herpes infection. Obstet Gynecol 2008;112(2 Pt 2):455–7.
  11. Garland SM, Hill PJ. Eczema herpeticum in pregnancy successfully treated with acyclovir. Aust N Z J Obstet Gynaecol 1994;34:214–5.
  12. Tony Burns, Stephen Breathnach, Neil Cox, Christopher Griffiths, editors. Rook's Textbook of Dermatology. 8th edn. Massachusetts: Blackwell Publishing, 2010.
  13. Latta RA, Baker DA. Treatment of recurrent eczema herpeticum in pregnancy with acyclovir. Infect Dis Obstet Gynecol 1996;4:239–42.
  14. Birnie AJ, Bath-Hextall FJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst Rev 2008(3):CD003871.


Yes     No

Declaration of competing interests *

Yes No

Additional Author (remove)

Yes No






Competing Interests: 

Your comment is being submitted, please wait


Download citation in RIS format (EndNote, Zotero, RefMan, RefWorks)

Download citation in BIBTEX format (RefMan)

Download citation in REFER format (EndNote, Zotero, RefMan, RefWorks)

For more information see Wikipedia: Comparison of reference management software